ZYMEWORKS INC. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (12)

Latest Posts

About This Stock More About This Stock
E Money Monday
Article By: Vivian Lewis
Monday, August 3, 2020 6:25 PM EDT
Today, after the pileup of results last week, markets caught their breath and rose. We had good news from a Japanese favorite, bad news from a British bank we sold, and good news for a Chinese firm.The Dow is up too.
In this article: GSK, NIO, ITRN, MSFT, QCOM, TEVA, ZYME
Read
E No Memorial Today
Article By: Vivian Lewis
Tuesday, October 22, 2019 11:55 PM EDT
Our sold stocks are crashing and our bought stocks climbing! We have reports from the USA, Japan, Israel, Denmark, and Canada, and that's only about pharmaceuticals. We also have exciting news about lung cancer, but some bad news from India...
In this article: BMY, NVO, ESALY, GNCGY, NPSNY, BIIB, INFY, TEVA, ZYME, PROSY, EC, SLB, SQM, CMDXF, JMPLY, ITRN, LBTYA, LBTYK, CZZ, TMRAF, SAN, ANFGF, AZSEY, ACAT, CBBYF
Read
E Markets Calm Down On Brexit And China Trade News
Article By: Vivian Lewis
Sunday, October 13, 2019 12:52 PM EDT
Two of the things terrifying markets looked somewhat more hopeful Friday as Brexit progresses and China agreed on a partial trade deal.
In this article: VEOEY, SAXPY, STADF, INFY, ZYME, MELI, MMYT, MNILY, BP, AQN
Read
E American Depositary Receipts
Article By: Vivian Lewis
Thursday, June 27, 2019 12:01 AM EDT
The medical devices firm Smith & Nephew pondered creating an ADR listing in order to pay their new CEO Narnal Nawana a higher salary than would have been tolerated by UK shareholders. And more on global stocks.
In this article: ANFGF, CRH, GNCGY, MELI, NPSNY, TCEHY, AAIGF, TEVA, AGN, ZYME, VOD, CGEN, GNFTF, BHC, BT, AQN, DCMYY, AZRE, FBASF, GLD
Read
Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody Deal With Zymeworks
Article By: ChinaBio® Today
Saturday, December 1, 2018 4:44 PM EDT
BeiGene of Beijing announced cancer drug deals worth up to $1.3 billion with Vancouver's Zymeworks. BeiGene will acquire Asian rights to two bispecific antibodies from Zymeworks and will have rights to three to-be-discovered bispecific candidates.
In this article: LLY, HCM, BGNE, MGNX, ZLAB, TCON, ZYME, BHVN
Read

PARTNER HEADLINES

Latest Tweets for $ZYME

No tweets yet!